EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access

Validation of a modified rapid test to detect the cefazolin inoculum effect in methicillin-susceptible Staphylococcus aureus from bloodstream infections in hospitals from North and Latin America

Sara I Gomez-Villegas, Sandra Rincon, Lina P Carvajal, J Manuel Matiz-González, Diana Panesso, Truc T Tran, Erika Flores, Jacob Dziadula, Rodrigo Baptista, Tanis C Dingle, Jennifer Dien Bard iD, April Abbott und 7 weitere

Journal of Antimicrobial Chemotherapy · 2025

DOI: 10.1093/jac/dkaf093 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2025. Verfasst von Sara I Gomez-Villegas und 18 weiteren Autor:innen. Beteiligte Einrichtung: Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Cefazolin, Bacteremia, Staphylococcal Infections. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Institute of Allergy and Infectious Diseases, NIAID NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The cefazolin inoculum effect (CzIE), defined here as a cefazolin MIC at high inoculum (107 colony-forming units/mL) ≥16 mg/L in MSSA, has been associated with less favourable clinical outcomes. However, detection of this phenotype is challenging in the clinical microbiology laboratory. We previously described modification of a rapid nitrocefin test using ampicillin disks rather than ampicillin powder for induction of the Staphylococcus aureus β-lactamase (BlaZ).

Objective

Evaluate the performance of the modified rapid nitrocefin test in a blinded fashion using MSSA isolates recovered from patients with bacteraemia.

Methods

We evaluated 200 MSSA isolates recovered from Latin American (LA) and North American (NA) hospitals (67 and 133 from NA and LA, respectively). The CzIE was determined using the modified rapid nitrocefin test with ampicillin disks and compared with MIC determination at high inoculum (gold standard). All isolates were subjected to whole-genome sequencing on an Illumina Hi-Seq platform. Performance metrics were calculated for the complete dataset and according to specific BlaZ types.

Results

The prevalence of the CzIE was 53% (105/200). Compared with the gold standard, the modified nitrocefin rapid test had a sensitivity of 96% and a specificity of 91.6%, with an overall accuracy of 94%. There were no false-positive results among blaZ-negative MSSA strains.

Conclusions

The modified nitrocefin rapid test exhibited a robust performance to detect the CzIE in isolates from the Americas. This methodology is inexpensive and can be implemented in clinical microbiology laboratories around the world, including those with limited resources.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsCefazolinBacteremiaStaphylococcal InfectionsStaphylococcus aureusHumansMicrobial Sensitivity TestsLatin AmericaHospitalsNorth Americabeta-LactamasesWhole Genome SequencingSensitivity and Specificity

Substanzen

Anti-Bacterial AgentsCefazolinbeta-Lactamases

Autor:innen und Institutionen

  • Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Molecular Genetics and Antimicrobial Resistance Unit, Universidad El Bosque, Bogota, Colombia.
  • Center for Infectious Diseases, Houston Methodist Research Institute, Houston, TX, USA.
  • Division of Infectious Diseases, Department of Medicine, Houston Methodist Hospital, Houston, TX, USA.
  • Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
  • Alberta Precision Laboratories, Public Health Laboratory, Calgary, Alberta, Canada.

ORCID-Profile: Jennifer Dien Bard, Stephanie Fritz, William R Miller, Jinnethe Reyes

Förderung

  • National Institute of Allergy and Infectious Diseases
  • NIAID NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Gomez-Villegas, S. I., Rincon, S., Carvajal, L. P., Matiz-González, J. M., Panesso, D., Tran, T. T., Flores, E., Dziadula, J., Baptista, R., Dingle, T. C., Dien Bard, J., Abbott, A., Burnham, C. D., Fritz, S., Westblade, L. F., Butler-Wu, S., Miller, W. R., Arias, C. A., & Reyes, J. (2025). Validation of a modified rapid test to detect the cefazolin inoculum effect in methicillin-susceptible Staphylococcus aureus from bloodstream infections in hospitals from North and Latin America. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkaf093

Vancouver

Gomez-Villegas SI, Rincon S, Carvajal LP, Matiz-González JM, Panesso D, Tran TT, et al. Validation of a modified rapid test to detect the cefazolin inoculum effect in methicillin-susceptible Staphylococcus aureus from bloodstream infections in hospitals from North and Latin America. Journal of Antimicrobial Chemotherapy. 2025. doi:10.1093/jac/dkaf093

BibTeX
@article{GomezVillegas2025,
  author = {Gomez-Villegas, Sara I and Rincon, Sandra and Carvajal, Lina P and Matiz-González, J Manuel and Panesso, Diana and Tran, Truc T and Flores, Erika and Dziadula, Jacob and Baptista, Rodrigo and Dingle, Tanis C and Dien Bard, Jennifer and Abbott, April and Burnham, Carey-Ann D and Fritz, Stephanie and Westblade, Lars F and Butler-Wu, Susan and Miller, William R and Arias, Cesar A and Reyes, Jinnethe},
  title = {Validation of a modified rapid test to detect the cefazolin inoculum effect in methicillin-susceptible Staphylococcus aureus from bloodstream infections in hospitals from North and Latin America},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2025},
  doi = {10.1093/jac/dkaf093}
}
Kostenlos starten →